咳止め薬市場：疾患タイプ、薬剤タイプ、年齢層、剤形、流通チャネル別-2025-2030年世界予測

咳止め薬市場は、2023年に19億8,000万米ドルと評価され、2024年には20億7,000万米ドルに達すると予測され、CAGR 4.63％で成長し、2030年には27億2,000万米ドルに達すると予測されています。

咳止め薬は、一般的に咳を緩和するために使用され、広範な医薬品市場の中でも重要なセグメントです。主に、これらの医薬品には処方薬と市販薬の両方が含まれます。咳止め薬の必要性は、呼吸器感染症、アレルギー、慢性閉塞性肺疾患のような疾患の流行によってもたらされ、症状緩和のための用途が大幅に拡大しています。最終用途は病院、診療所、家庭にまで広がっています。成長要因としては、呼吸器疾患の罹患率の増加、セルフメディケーションに対する消費者の意識の高まりなどが挙げられます。先進的な製剤の流入と小児用咳止め薬の重視が市場をさらに後押ししています。最近では、COVID-19後の健康への関心の高まりにより需要が急増しており、企業が健康志向の消費者を取り込むために眠くならない処方やハーブを使った副作用のない製剤を革新する潜在的な機会を提示しています。

反面、成長を阻む課題としては、厳しい規制基準や咳止め薬に関連する副作用の懸念などがあり、市場浸透を阻害する可能性があります。さらに、消費者の間でこれらの医薬品が誤解され誤用されることで、採用がためらわれる可能性もあります。これらの課題を軽減するために、研究開発はこれらの医薬品の安全性プロファイルと有効性の改善に焦点を当てることができます。天然成分スペクトルの探索、免疫増強特性を含む製剤の拡大、ロゼンジや速効性スプレーなどのドラッグデリバリーシステムの革新は、有望な分野です。全体として市場競争は緩やかで、主要企業が戦略的提携や買収に投資して製品ラインナップを増やし、流通網を改善するため、統合に傾いています。足跡の拡大を目指す企業にとって、現地の規制や消費者行動のニュアンスを理解することは、依然として極めて重要です。市場の性質上、技術の進歩、消費者の嗜好の変化、効果的な呼吸器疾患管理ソリューションへの継続的なニーズが原動力となり、着実な成長が見込まれます。

市場力学：急速に進化する咳止め薬市場の主要市場インサイトを公開

咳止め薬市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 慢性肺疾患患者の増加
  • 世界の喫煙者数の急増
  • 屋内および屋外におけるアレルゲンの出現
• 市場抑制要因
  • 治療に伴う莫大な費用と熟練労働者の不足
• 市場機会
  • 新しい治療法や薬剤の開発
  • 先進ヘルスケアインフラに対する政府の取り組み
• 市場の課題
  • 咳止め薬の副作用

ポーターの5つの力：咳止め薬市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、咳止め薬市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：咳止め薬市場における外部からの影響の把握

外部マクロ環境要因は、咳止め薬市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析咳止め薬市場における競合情勢の把握

咳止め薬市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス咳止め薬市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、咳止め薬市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨咳止め薬市場における成功への道筋を描く

咳止め薬市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 慢性肺疾患の増加
    • 世界中で喫煙者数が急増
    • 屋内および屋外の脆弱なアレルゲンの出現
  • 抑制要因
    • 治療にかかる莫大な費用と熟練労働者の不足
  • 機会
    • 新しい治療法や薬剤の開発
    • 先進的なヘルスケアインフラに向けた政府の取り組み
  • 課題
    • 咳止め薬の副作用
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 咳止め薬市場：疾患タイプ別

• 乾いた咳
• 湿った咳

第7章 咳止め薬市場薬の種類別

• ベンゾナテート
• ブタミラート
• コデイン
• デキストロメトルファン
• ノスカピン
• フォルコジン

第8章 咳止め薬市場：年齢層別

• 成人用
• 小児科

第9章 咳止め薬市場剤形別

• シロップ
• 錠剤

第10章 咳止め薬市場：流通チャネル別

• 病院
• オンライン薬局
• 小売ドラッグストア

第11章 南北アメリカの咳止め薬市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋地域の咳止め薬市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカの咳止め薬市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Acella Pharmaceuticals, LLC
• Alvizia Healthcare Private Limited
• Amneal Pharmaceuticals, Inc.
• Athens Labs Ltd.
• Aurobindo Pharma Limited
• Aytu BioScience, Inc.
• Bayer AG
• GlaxoSmithKline PLC
• Mayne Pharma, Inc.
• Pfizer Inc.
• Solace Biotech Ltd.
• Taro Pharmaceutical Industries
• Tris Pharma, Inc.
• Vernalis PLC
• Zenes Biotech Pvt. Ltd.

LIST OF FIGURES

• FIGURE 1. COUGH SUPPRESSANT DRUGS MARKET RESEARCH PROCESS
• FIGURE 2. COUGH SUPPRESSANT DRUGS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 19. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. COUGH SUPPRESSANT DRUGS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 25. COUGH SUPPRESSANT DRUGS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. COUGH SUPPRESSANT DRUGS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. COUGH SUPPRESSANT DRUGS MARKET DYNAMICS
• TABLE 7. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRY COUGH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY WET COUGH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY BENZONATATE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY BUTAMIRATE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CODEINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DEXTROMETHORPHAN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY NOSCAPINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PHOLCODINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY RETAIL DRUG STORE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 43. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 44. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 45. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 46. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 47. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 48. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 49. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 51. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 52. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 53. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 58. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 59. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 60. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 63. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 64. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 65. AUSTRALIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 66. AUSTRALIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 67. AUSTRALIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 68. AUSTRALIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 69. AUSTRALIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 70. CHINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 71. CHINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 72. CHINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 73. CHINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 74. CHINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 75. INDIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 76. INDIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 77. INDIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 78. INDIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 79. INDIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 80. INDONESIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 81. INDONESIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 82. INDONESIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 83. INDONESIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 84. INDONESIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 85. JAPAN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 86. JAPAN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 87. JAPAN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 88. JAPAN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 89. JAPAN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 90. MALAYSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 91. MALAYSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 92. MALAYSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 93. MALAYSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 94. MALAYSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 95. PHILIPPINES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 96. PHILIPPINES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 97. PHILIPPINES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 98. PHILIPPINES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 99. PHILIPPINES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 100. SINGAPORE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 101. SINGAPORE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 102. SINGAPORE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 103. SINGAPORE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 104. SINGAPORE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 105. SOUTH KOREA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 106. SOUTH KOREA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 107. SOUTH KOREA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 108. SOUTH KOREA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 109. SOUTH KOREA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 110. TAIWAN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 111. TAIWAN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 112. TAIWAN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 113. TAIWAN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 114. TAIWAN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 115. THAILAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 116. THAILAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 117. THAILAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 118. THAILAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 119. THAILAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 120. VIETNAM COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 121. VIETNAM COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 122. VIETNAM COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 123. VIETNAM COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 124. VIETNAM COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 125. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 126. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 129. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 130. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 131. DENMARK COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 132. DENMARK COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 133. DENMARK COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 134. DENMARK COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 135. DENMARK COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 136. EGYPT COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 137. EGYPT COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 138. EGYPT COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 139. EGYPT COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 140. EGYPT COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 141. FINLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 142. FINLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 143. FINLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 144. FINLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 145. FINLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 146. FRANCE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 147. FRANCE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 148. FRANCE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 149. FRANCE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 150. FRANCE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 151. GERMANY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 152. GERMANY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 153. GERMANY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 154. GERMANY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 155. GERMANY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 156. ISRAEL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 157. ISRAEL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 158. ISRAEL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 159. ISRAEL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 160. ISRAEL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 161. ITALY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 162. ITALY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 163. ITALY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 164. ITALY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 165. ITALY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 166. NETHERLANDS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 167. NETHERLANDS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 168. NETHERLANDS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 169. NETHERLANDS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 170. NETHERLANDS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 171. NIGERIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 172. NIGERIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 173. NIGERIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 174. NIGERIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 175. NIGERIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 176. NORWAY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 177. NORWAY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 178. NORWAY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 179. NORWAY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 180. NORWAY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 181. POLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 182. POLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 183. POLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 184. POLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 185. POLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 186. QATAR COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 187. QATAR COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 188. QATAR COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 189. QATAR COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 190. QATAR COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 191. RUSSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 192. RUSSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 193. RUSSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 194. RUSSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 195. RUSSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 196. SAUDI ARABIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 197. SAUDI ARABIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 198. SAUDI ARABIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 199. SAUDI ARABIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 200. SAUDI ARABIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 201. SOUTH AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 202. SOUTH AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 203. SOUTH AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 204. SOUTH AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 205. SOUTH AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 206. SPAIN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 207. SPAIN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 208. SPAIN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 209. SPAIN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 210. SPAIN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 211. SWEDEN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 212. SWEDEN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 213. SWEDEN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 214. SWEDEN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 215. SWEDEN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 216. SWITZERLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 217. SWITZERLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 218. SWITZERLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 219. SWITZERLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 220. SWITZERLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 221. TURKEY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 222. TURKEY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 223. TURKEY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 224. TURKEY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 225. TURKEY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 226. UNITED ARAB EMIRATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 227. UNITED ARAB EMIRATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 228. UNITED ARAB EMIRATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 229. UNITED ARAB EMIRATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 230. UNITED ARAB EMIRATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 231. UNITED KINGDOM COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 232. UNITED KINGDOM COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 233. UNITED KINGDOM COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 234. UNITED KINGDOM COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 235. UNITED KINGDOM COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 236. COUGH SUPPRESSANT DRUGS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 237. COUGH SUPPRESSANT DRUGS MARKET, FPNV POSITIONING MATRIX, 2023

The Cough Suppressant Drugs Market was valued at USD 1.98 billion in 2023, expected to reach USD 2.07 billion in 2024, and is projected to grow at a CAGR of 4.63%, to USD 2.72 billion by 2030.

Cough suppressant drugs, commonly used to alleviate coughing, are a significant segment within the broader pharmaceutical market. Primarily, these drugs include both prescription and over-the-counter medications. The necessity for cough suppressants is driven by the prevalence of respiratory infections, allergies, and ailments like chronic obstructive pulmonary disorder, significantly enhancing their application for symptomatic relief. End-use extends across hospitals, clinics, and even households. Influencing growth factors include the increasing incidence of respiratory diseases and rising consumer awareness towards self-medication. The influx of advanced drug formulations and an emphasis on pediatric cough suppressants further propels the market. Lately, there has been a surge in demand due to a heightened focus on health post-COVID-19, presenting potential opportunities for firms to innovate in non-drowsy formulas and herbal, side-effect-free variants to capture health-conscious consumers.

On the flip side, limitations challenging growth include stringent regulatory standards and side-effect concerns associated with cough suppressants, which may impede market penetration. Additionally, the misinterpretation and misuse of these medications among consumers can lead to hesitancy in adoption. To mitigate these challenges, research and development can focus on improving the safety profile and efficacy of these drugs. Exploring the natural ingredient spectrum, broadening formulations to include immuno-boosting properties, and innovating in drug delivery systems such as lozenges or fast-acting sprays are promising areas. Overall, the market remains moderately competitive, with a tilt towards consolidation as leading companies invest in strategic partnerships and acquisitions to broaden their product lines and improve distribution networks. Understanding local regulations and consumer behavior nuances remain pivotal for companies aiming to expand their footprint. The market's nature suggests steady growth potential, driven by technological advancements, shifting consumer preferences, and a continual need for effective respiratory ailment management solutions.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cough Suppressant Drugs Market

The Cough Suppressant Drugs Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increase in the cases of chronic lung disorders
  • Surge in the number of smokers globally
  • Emergence in vulnerable indoor as well as outdoor allergens
• Market Restraints
  • Huge cost associated with treatment and shortage of skilled labor
• Market Opportunities
  • Development of novel therapies and drugs
  • Government initiatives for advanced healthcare infrastructures
• Market Challenges
  • Side impacts of cough suppressant drugs

Porter's Five Forces: A Strategic Tool for Navigating the Cough Suppressant Drugs Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cough Suppressant Drugs Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cough Suppressant Drugs Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cough Suppressant Drugs Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cough Suppressant Drugs Market

A detailed market share analysis in the Cough Suppressant Drugs Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cough Suppressant Drugs Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cough Suppressant Drugs Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cough Suppressant Drugs Market

A strategic analysis of the Cough Suppressant Drugs Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cough Suppressant Drugs Market, highlighting leading vendors and their innovative profiles. These include Acella Pharmaceuticals, LLC, Alvizia Healthcare Private Limited, Amneal Pharmaceuticals, Inc., Athens Labs Ltd., Aurobindo Pharma Limited, Aytu BioScience, Inc., Bayer AG, GlaxoSmithKline PLC, Mayne Pharma, Inc., Pfizer Inc., Solace Biotech Ltd., Taro Pharmaceutical Industries, Tris Pharma, Inc., Vernalis PLC, and Zenes Biotech Pvt. Ltd..

Market Segmentation & Coverage

This research report categorizes the Cough Suppressant Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Disease Type, market is studied across Dry Cough and Wet Cough.
• Based on Drug Type, market is studied across Benzonatate, Butamirate, Codeine, Dextromethorphan, Noscapine, and Pholcodine.
• Based on Age Group, market is studied across Adult and Pediatric.
• Based on Dosage Form, market is studied across Syrup and Tablet.
• Based on Distribution Channel, market is studied across Hospital, Online Pharmacy, and Retail Drug Store.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increase in the cases of chronic lung disorders
    • 5.1.1.2. Surge in the number of smokers globally
    • 5.1.1.3. Emergence in vulnerable indoor as well as outdoor allergens
  • 5.1.2. Restraints
    • 5.1.2.1. Huge cost associated with treatment and shortage of skilled labor
  • 5.1.3. Opportunities
    • 5.1.3.1. Development of novel therapies and drugs
    • 5.1.3.2. Government initiatives for advanced healthcare infrastructures
  • 5.1.4. Challenges
    • 5.1.4.1. Side impacts of cough suppressant drugs
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Cough Suppressant Drugs Market, by Disease Type

• 6.1. Introduction
• 6.2. Dry Cough
• 6.3. Wet Cough

7. Cough Suppressant Drugs Market, by Drug Type

• 7.1. Introduction
• 7.2. Benzonatate
• 7.3. Butamirate
• 7.4. Codeine
• 7.5. Dextromethorphan
• 7.6. Noscapine
• 7.7. Pholcodine

8. Cough Suppressant Drugs Market, by Age Group

• 8.1. Introduction
• 8.2. Adult
• 8.3. Pediatric

9. Cough Suppressant Drugs Market, by Dosage Form

• 9.1. Introduction
• 9.2. Syrup
• 9.3. Tablet

10. Cough Suppressant Drugs Market, by Distribution Channel

• 10.1. Introduction
• 10.2. Hospital
• 10.3. Online Pharmacy
• 10.4. Retail Drug Store

11. Americas Cough Suppressant Drugs Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Cough Suppressant Drugs Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Cough Suppressant Drugs Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Acella Pharmaceuticals, LLC
• 2. Alvizia Healthcare Private Limited
• 3. Amneal Pharmaceuticals, Inc.
• 4. Athens Labs Ltd.
• 5. Aurobindo Pharma Limited
• 6. Aytu BioScience, Inc.
• 7. Bayer AG
• 8. GlaxoSmithKline PLC
• 9. Mayne Pharma, Inc.
• 10. Pfizer Inc.
• 11. Solace Biotech Ltd.
• 12. Taro Pharmaceutical Industries
• 13. Tris Pharma, Inc.
• 14. Vernalis PLC
• 15. Zenes Biotech Pvt. Ltd.